- Report
- January 2026
- 181 Pages
Global
From €4088EUR$4,500USD£3,528GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,520GBP
- Report
- June 2026
- 497 Pages
Global
From €5314EUR$5,850USD£4,587GBP
- Report
- June 2026
- 405 Pages
Global
From €5314EUR$5,850USD£4,587GBP
- Report
- June 2026
- 541 Pages
Global
From €5314EUR$5,850USD£4,587GBP
- Report
- June 2026
- 213 Pages
Global
From €5314EUR$5,850USD£4,587GBP
- Report
- May 2026
- 180 Pages
Global
From €4315EUR$4,750USD£3,724GBP
- Report
- May 2026
- 110 Pages
Global
From €4315EUR$4,750USD£3,724GBP
- Report
- April 2026
- 180 Pages
Global
From €4315EUR$4,750USD£3,724GBP
- Report
- April 2026
- 120 Pages
Global
From €4315EUR$4,750USD£3,724GBP
- Report
- February 2026
- 148 Pages
Global
From €3588EUR$3,950USD£3,097GBP
- Report
- November 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,803GBP
- Report
- April 2026
- 160 Pages
Global
From €3770EUR$4,150USD£3,254GBP
- Report
- November 2025
- 160 Pages
Global
From €3588EUR$3,950USD£3,097GBP
- Report
- October 2025
- 160 Pages
Global
From €3588EUR$3,950USD£3,097GBP
- Report
- July 2025
- 257 Pages
Global
From €4538EUR$4,995USD£3,916GBP
- Report
- October 2025
- 160 Pages
Global
From €3588EUR$3,950USD£3,097GBP
- Report
- February 2026
- 115 Pages
Global
From €3500EUR$4,127USD£3,126GBP

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more